Underrepresented Populations in Parkinson’s Genetics Research: Current Landscape and Future Directions
Output Details
Published January 31, 2022
- Review
Meet the Authors
-
Artur Francisco Shumacher-Schuh
External Collaborator
-
Andrei Bieger
External Collaborator
-
Olaitan Okunoye
External Collaborator
-
Kin Ying
External Collaborator
-
Shen-Yang Lim
External Collaborator
-
Soraya Bardien
External Collaborator
-
Azlina Ahman-Annuar
External Collaborator
-
Bruno Lopes Santos-Lobato
External Collaborator
-
Matheus Zschornack Strelow
External Collaborator
-
Mohamed Salama
External Collaborator
-
Shilpa C. Rao
External Collaborator
-
Yared Zenebe Zewde
External Collaborator
-
Saiesha Dindayal
External Collaborator
-
Jihan Azar
External Collaborator
-
Lingappa Kukkle Prashanth
External Collaborator
-
Roopa Rajan
External Collaborator
-
Alastair J Noyce
External Collaborator
-
Njideka Okubadejo
External Collaborator
-
Mie Rizig
External Collaborator
-
Suzanne Lesage
External Collaborator
-
Ignacia Fernandez Mata
External Collaborator
Related Research
Scientific Perspectives: Structural Biology of LRRK2 and its Interaction with Microtubules
Mutations in LRRK2 are linked to Parkinson's disease. LRRK2 regulates membrane trafficking and interacts with microtubules. Recent studies have revealed its cytosolic and microtubule-bound forms using cryo-EM and cryo-ET techniques.
Role of autophagy pathway in Parkinson’s disease and related Genetic Neurological disorders
The authors provide a comprehensive overview of the general importance of autophagy in Parkinson’s disease (PD) and related disorders of the central nervous system (CNS).
Mechanisms Controlling Selective Elimination of Damaged Lysosomes
Lysophagy, triggered by membrane rupture, involves galectins binding to lysosomal contents to promote autophagic recycling. Damaged lysosomes are ubiquitylated, leading to autophagosome formation for degradation in healthy lysosomes.